Commonwealth Equity Services
INMB icon

Commonwealth Equity Services’s INmune Bio INMB Stock Holding History

Commonwealth Equity Services’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,905
Closed -$39K – 4342
2025
Q2 		$39K Sell
16,905
-2,983
-15% -$21.9K ﹤0.01% 4182
2025
Q1 		$155K Buy
+19,888
New +$158K ﹤0.01% 3906

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Commonwealth Equity Services's INMB Position: Q3 2025 in Review

Commonwealth Equity Services sold out of INmune Bio (INMB) in Q3 2025, closing a stake of 16,905 shares — an estimated $39K sold.

Commonwealth Equity Services first reported a position in INMB in Q1 2025 and held it in 2 quarters. The position peaked at $155K in Q1 2025. 73 funds tracked by Wall St. Rank hold INMB as of Q3 2025.

  • Commonwealth Equity Services reported no remaining INmune Bio position as of Q3 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 16,905 INmune Bio shares in Q3 2025, an estimated $39K.
  • Commonwealth Equity Services first reported a position in INmune Bio in Q1 2025 and held it in 2 quarters.
  • Commonwealth Equity Services's INmune Bio position peaked at $155K in Q1 2025.
  • 73 funds tracked by Wall St. Rank held INmune Bio as of Q3 2025.

Based on Commonwealth Equity Services's 13F filing for Q3 2025, filed 22 Oct 2025.